Zhaowei Feng | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Dr. Zhaowei Feng | Stem Cell Research | Best Researcher Award

Dr. Zhaowei Feng, The Second Affiliated Hospital of Xuzhou Medical University, China

Zhaowei Feng is a dedicated biomedical researcher specializing in neurobiology and pharmacology, currently serving as an Assistant Researcher at The Second Affiliated Hospital of Xuzhou Medical University. With a solid academic foundation and a passion for neuroscience, Feng has made significant contributions to understanding mechanisms of neuroprotection and demyelination. His research spans neurodegenerative disease models such as multiple sclerosis and neonatal hypoxia-ischemia, utilizing molecular and cellular biology tools. Known for his collaborative nature and scientific rigor, Feng has co-authored multiple peer-reviewed articles in prestigious journals and has played pivotal roles in various national and municipal-level research projects. He is particularly recognized for co-first authorship in several studies, reflecting leadership in experimental design and data analysis. His growing influence in the field is further supported by ongoing funded projects and a research trajectory aimed at translational outcomes. Feng is committed to continuing impactful research that bridges bench science with clinical applications.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Strong Research Focus in Neurobiology 🧠
    Zhaowei Feng has a consistent and impactful research portfolio in neurobiology, particularly in myelination, ischemia-reperfusion injury, and glutamate signaling. His work is highly relevant in addressing diseases like multiple sclerosis and neonatal hypoxia-ischemia encephalopathy.

  2. Publications in High-Impact Journals 📚
    He has co-authored several peer-reviewed journal articles in reputable journals such as Phytomedicine, Pharmacology, Oncology Reports, and Frontiers. His contributions as co-first author in multiple papers reflect significant involvement in study design and experimentation.

  3. Independent Researcher Role 🧪
    He currently serves as a Principal Investigator for a municipal-level research project funded by the Xuzhou Health Commission, demonstrating trust in his leadership and research direction.

  4. Multidisciplinary Expertise 🔬
    His research integrates pharmacology, molecular biology, and neuroscience, covering diverse mechanisms like PPARγ signaling, SUMOylation, and ferroptosis, which enhances translational potential.

  5. Rapid Academic Growth 🚀
    Transitioning quickly from a Master’s student (2019–2022) to Assistant Researcher and PI (since 2022) shows a fast-tracked academic trajectory.

⚠️ Areas for Improvement:

  1. Need for More First-Author and Corresponding-Author Papers ✍️
    While co-first authorship is commendable, a stronger emphasis on sole first or corresponding authorship in future publications would establish more scientific independence.

  2. Limited Recognition at National Level 🏅
    Most current funding and achievements are at the municipal level. Applying for national or international grants (e.g., NSFC, NIH) would elevate his research profile.

  3. Postdoctoral Training or Collaboration Abroad 🌍
    Gaining international experience or collaborating with global research centers could broaden perspectives and techniques, increasing citation impact and networking.

  4. More Diversified Research Outputs 📊
    Exploring patents, clinical trials, or translational research outcomes could further demonstrate innovation and application potential.

🎓 Education:

Zhaowei Feng began his academic journey in the biological sciences at Xuzhou Medical University, where he earned his Bachelor’s degree between 2014 and 2018. He further pursued a Master’s degree in Neurobiology at the same institution from September 2019 to July 2022. His graduate studies were marked by an intensive focus on neurodegenerative mechanisms, including demyelination and neuroinflammation, with particular attention to cuprizone-induced and ischemia-reperfusion mouse models. His research also explored glutamate transport regulation, the PPARγ pathway, and oligodendrocyte differentiation. His educational foundation not only provided him with technical proficiency in experimental neuroscience but also cultivated a strong understanding of translational biomedical research. Through rigorous coursework, laboratory experience, and thesis writing, Feng developed a robust academic profile that seamlessly transitioned into his research career. His educational journey reflects consistent dedication and a clear trajectory towards clinical and experimental neurobiology.

🧪 Experience:

Since September 2022, Zhaowei Feng has been working as an Assistant Researcher at The Second Affiliated Hospital of Xuzhou Medical University. His role involves leading preclinical studies, managing collaborative projects, and mentoring junior researchers. Feng has also served as Principal Investigator on a municipal-level research grant focusing on blood-brain barrier damage post-transplantation. He actively participates in multiple interdisciplinary studies involving neurodevelopment, myelination, and pharmacological interventions. Prior to his current role, his Master’s research provided hands-on experience with animal models, molecular techniques, and data analysis in neurobiology. Feng has authored or co-authored numerous research papers, some as co-first author, contributing significantly to study design and execution. He is also involved in translational research projects that aim to bridge laboratory findings with clinical therapies. His work ethic, attention to detail, and innovative approach make him a valuable contributor to the field of neurobiological research.

🏅 Awards and Honors:

Zhaowei Feng has been recognized for his scientific contributions through both academic and research-oriented accolades. Notably, he is the recipient of a research grant from the Xuzhou Municipal Health Commission (Project No. XWKYHT20230029), focusing on cerebral ischemia-reperfusion and blood-brain barrier injury. Though early in his professional career, his selection as Principal Investigator on this project signifies trust in his leadership and expertise. Several of his publications in high-impact journals list him as co-first author—an honor that highlights his equal contribution in rigorous experimental work. While he has yet to receive national awards such as from the Natural Science Foundation, his steady academic output and funded research projects mark a strong trajectory. His growing publication record and role in significant studies position him as a rising talent in the biomedical field. Future honors are likely as his research continues to address key questions in neuroscience and pharmacology.

🔬 Research Focus:

Zhaowei Feng’s research centers on neuroprotection, demyelination, and neuroinflammation, with a particular focus on the mechanisms underlying multiple sclerosis, ischemic brain injury, and neonatal encephalopathy. His studies often employ animal models such as cuprizone-induced demyelination and hypoxia-ischemia to explore therapeutic targets. Feng is particularly interested in the regulation of oligodendrocyte differentiation and the role of glutamate transporters, signaling molecules like PPARγ, and pathways involving Wnt/β-catenin and SUMOylation. Additionally, he has investigated compounds such as diosgenin and alpha-asaronol for their neuroprotective and remyelination-promoting effects. His work also extends into cancer biology, with studies on ferroptosis and protein regulation in squamous cell carcinoma. By integrating molecular biology, pharmacology, and neurodevelopmental research, Feng aims to contribute to the discovery of new treatments for central nervous system disorders. His current and future research is geared toward translational medicine that bridges laboratory science with clinical applications.

📚 Publication Top Notes:

  1. 🧠 Alpha-Asaronol Alleviates Dysmyelination by Enhancing Glutamate Transport via PPARγ-GLT-1 Signaling in Neonatal Hypoxia-Ischemia (Pharmacology, 2022)

  2. 🧬 C1q Inhibits Differentiation of Oligodendrocyte Progenitor Cells via Wnt/β-Catenin Signaling (Biomedicine & Pharmacotherapy, 2023)

  3. 🧪 Alpha-Asaronol Promoted OPC Differentiation and Improved Myelination as a PPARγ Activator (Frontiers, 2023)

  4. 🧫 Diosgenin Promoted OPC Differentiation by Blocking GLUR2/GAPDH Interaction in Pilocarpine-Induced Epilepsy Rats (Phytomedicine, 2025)

  5. 🧬 Netrin-4 Mediates Piezo1 Inactivation and YAP Signaling Alleviation in Cerebral Ischemia-Reperfusion (Oncology Reports)

  6. 🔬 SENP1 Inhibits Ferroptosis and Promotes Head and Neck Squamous Cell Carcinoma by Regulating ACSL4 Protein (Molecular Oncology, 2023)

  7. 🧪 SUMO1-Mediated Stabilization Enhances Protein Function in Neuroinflammatory Models (Unspecified Journal)

  8. 🧠 Signaling Activation in a Cuprizone-Induced Mouse Model of Multiple Sclerosis (Unspecified Journal)

📌 Conclusion:

Zhaowei Feng is a highly promising early-career researcher with a clear scientific focus, a growing publication record, and demonstrated ability to lead independent research. His work addresses critical challenges in neurobiology and pharmacology, making a tangible impact in both experimental and translational medicine. With continued progression—especially toward national-level recognition and senior authorship—he has the potential to become a leader in his field.

Aime Christian Kayath | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Aime Christian Kayath | Microbial Cell Biology | Best Researcher Award

Prof. Aime Christian Kayath, Marien NGOUABI University, Republic of the Congo

Dr. Christian Aimé Kayath is a Congolese biotechnologist, academic, and scientific leader with over two decades of experience in teaching, research, and science policy. Currently serving as the Director of Cooperation at the Ministry of Higher Education, Scientific Research and Technological Innovation (MESRSIT) in the Republic of Congo, he is also a CAMES-accredited Research Professor at Marien Ngouabi University. With a strong foundation in microbiology, molecular biology, and biotechnology, Dr. Kayath has authored over 70 peer-reviewed publications and supervised more than 100 dissertations. His research spans bioremediation, biosurfactants, and fermented food technology. A multilingual scholar fluent in French and English, he has also held research and teaching roles in Belgium, significantly shaping Congo’s scientific infrastructure. He is known for his dedication to academic excellence and public science engagement, as reflected in his creation of educational movements and leadership in cultural organizations.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. 🔬 Robust Research Output

    • 71 peer-reviewed journal articles, 1 book, and 10+ supervised theses.

    • h-index of 9, with 311 citations and a Research Interest Score of 526.8 on ResearchGate.

    • Published consistently in reputable journals like International Journal of Microbiology and Journal of Pathogens.

  2. 👨‍🏫 Academic & Mentorship Leadership

    • Over 100 dissertations supervised since 2015, showing commitment to academic mentorship.

    • Active as a CAMES Lecturer, Research Professor, and Head of a Research Laboratory.

  3. 🌍 International & Policy Experience

    • Held senior roles in government ministries (MRSIT, MESRSIT) as Director of Cooperation and Scientific Activities.

    • Experience across Congo and Belgium, including universities and research institutes.

    • Served as National Liaison Officer (NLO) with the IAEA (2014–2023), indicating global collaboration in science and technology.

  4. 📚 Multidisciplinary Expertise

    • Specialized in biotechnology, molecular biology, microbiology, and biosurfactants.

    • Also skilled in e-management, IT tools, and web design, showcasing adaptability and cross-functional capabilities.

  5. 🫂 Community & Social Engagement

    • Founder of the social education movement “L’école ke bien, l’école ke futa” to fight school dropouts.

    • President of a historic choir with 200+ members, highlighting leadership in civil society.

⚠️ Areas for Improvement:

  • 🌐 Global Collaboration Expansion

    • Although strong in Africa and Europe, expanding collaborations to North America or Asia could enhance his global academic influence.

  • 📱 Digital Visibility

    • A dedicated academic website, active LinkedIn profile, or Google Scholar page would improve public and institutional access to his achievements.

  • 🎯 Citation and Impact

    • While his h-index (9) and citation count (311) are respectable, targeting high-impact journals could elevate his academic footprint further.

🎓 Education:

Dr. Kayath’s academic journey began at Marien Ngouabi University (Congo) with a Bachelor’s degree in Cell Biology and Physiology (1999–2000), followed by a Master’s in Cellular and Molecular Biology (2000–2001). He later pursued a DES in Biotechnology with Distinction at the University of Liège, Belgium (2003–2005), before completing a PhD in Biotechnology–Biochemistry–Molecular Biology (2005–2010), where he graduated with honors. His education is enhanced by complementary training in e-management and business administration (2008–2009, Brussels), which supports his administrative expertise. Dr. Kayath has consistently merged academic rigor with applied science and policy, reflecting a versatile and forward-thinking scholar. His multidisciplinary background underpins his work in biosciences, research governance, and international cooperation.

💼 Professional Experience:

Dr. Kayath’s career includes significant roles in academia, research, and science governance. He has served as Research Professor and Head of Laboratory of Applied Microbiology and Molecular Biology at IRSEN/MESRSIT since 2014. He was previously Scientific Attaché (2015–2016), Director of Scientific Activities (2019–2021), and currently serves as Director of Cooperation at MESRSIT. Internationally, he worked in Belgium as a Senior Scientist at Ovogenics (2011–2012), Project Developer at CERP Haren (2010–2011), and Assistant Professor at the University of Brussels (2008–2011). Earlier, he taught biology at Lycée Ecole Actuel and the International University of Brazzaville. He also acted as NLO for the IAEA (2014–2023), enhancing nuclear science cooperation. His professional path showcases a strong alignment between scientific leadership and practical impact.

🔬 Research Focus:

Dr. Kayath’s research specializes in microbial biotechnology, with a focus on biosurfactant production, bioremediation, microbial fermentation, and pathogen control. His investigations explore the role of indigenous Bacillus strains in soil cleanup and food preservation, alongside the biomedical enhancement of fermented products. He has studied Shigella flexneri’s biosurfactant mechanisms, polyphenol enhancement in ginger fermentation, and biosurfactants in plantain wine. His research directly addresses health, food security, and environmental issues in Sub-Saharan Africa and beyond. Dr. Kayath integrates molecular biology, biochemistry, and microbial ecology, often applying meta-analytical techniques and PCR methods. His ability to blend applied research with policy has made him a bridge between science and governance, reinforcing national research strategies in Congo. His work is widely cited, and he continues to contribute to sustainable innovation in African biotechnology.

📚 Publications Top Notes: 

  1. 🧫 High Efficacy of Rose Bengal in Reducing the Pathogenicity of Escherichia coli – Int. J. of Microbiology (2025)

  2. 🍛 Evolution of Fermented Food Products in the Republic of Congo: A Meta-analytic Review – J. of Advances in Microbiology (2024)

  3. 🌱 Bacillus Species Consortium as a New Starter in Cassava Retting – Int. J. of Microbiology & Biotechnology (2024)

  4. 🧪 Involvement of Bacillus SecYEG Pathway in Biosurfactant Production and Biofilm Formation – Int. J. of Microbiology (2024)

  5. 🛢 Profiling of Indigenous Biosurfactant-Producing Bacillus Isolates in Bioremediation – Int. J. of Microbiology (2021)

  6. 🔬 Prime Enzymatic Exocellular Background of Lysinibacillus louembei – Advances in Microbiology (2020)

  7. 🍹 Synergic Involvements of Microorganisms in Fermented Ginger Juice – Int. J. of Microbiology (2020)

  8. 🧫 Invasion of Epithelial Cells via T3SS of Shigella flexneri – J. of Pathogens (2020)

  9. 🧬 Invasion of Epithelial Cells via T3SS of Shigella flexneri (Preprint) – bioRxiv (2020)

  10. 🍷 Benefits of Biosurfactants from Lactic Acid Bacteria in Plantain Wine – Advances in Microbiology (2019)

🧾 Conclusion:

Dr. Christian Aimé Kayath is an exceptionally qualified and well-rounded researcher, merging high-level academic output with administrative leadership and societal engagement. His prolific publication record, contribution to education policy, international collaborations, and mentorship excellence make him highly suitable for the Best Researcher Award.

Rodrigo Navarro | Tissue Engineering | Tissue Engineering Award

Published on by Cell Biologist

Dr. Rodrigo Navarro | Tissue Engineering | Tissue Engineering Award

Dr. Rodrigo Navarro, Institute of Polymer Science and Technology, Spain

Dr. Rodrigo Navarro Crespo is a Tenured Scientist at the Spanish National Research Council (CSIC), specializing in polymer science and materials chemistry. With a solid foundation in chemistry and an internationally-recognized research profile, he has contributed significantly to the development of advanced polymeric materials with environmental and biomedical applications. His scientific work focuses on sustainable materials, plasticizer migration suppression, polymer surface modification, and chemical recycling. Dr. Navarro has published extensively in high-impact journals and collaborated with researchers across Europe. His ability to innovate in polymer processing, particularly through green chemistry and circular economy principles, positions him at the forefront of modern materials science. In 2020, he was awarded the Best Paper Award by the European Membrane Society. Dr. Navarro’s experience, interdisciplinary mindset, and research excellence make him a strong candidate for recognition in fields like tissue engineering, where advanced and sustainable polymer design is increasingly critical.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Interdisciplinary Expertise: Dr. Navarro’s research integrates polymer chemistry, materials science, and green chemistry, which are highly relevant for tissue engineering. His expertise in designing bio-inspired polyurethanes and non-migrating plasticized polymers aligns with the need for biocompatible, durable, and safe scaffolding materials in regenerative medicine.

  2. Innovation in Polymer Modification: His work on PVC modification, covalent plasticizer bonding, and functional surface-attached polymer layers demonstrates strong potential for developing customized materials with controlled biodegradability and mechanical properties suitable for tissue scaffolds.

  3. Environmental Sustainability Focus: His award-winning contributions to the circular economy, especially the upcycling of PET and membrane recycling, show leadership in sustainable material innovation — a growing priority in biomedical applications.

  4. Publication Impact & Recognition: With highly cited publications in Macromolecules, Langmuir, and Journal of Membrane Science, and the 2020 Best Paper Award, he is a well-recognized expert in polymer systems, which strengthens his academic profile for any prestigious research award.

📌 Areas for Improvement:

  1. Direct Application to Tissue Engineering: While his research strongly supports materials design, there’s limited direct evidence of his work being applied in biological systems such as cell culture, in vivo testing, or tissue integration studies. Expanding collaborations with biomedical researchers or publishing in biomedical journals could solidify his relevance in tissue engineering.

  2. Translational Research Output: Most contributions are fundamental or materials-based; showcasing functional prototypes, patents, or clinical collaborations would boost his impact in the translational science domain where tissue engineering advances often occur.

  3. Broader International Leadership: While experienced and internationally trained, more visibility in international tissue engineering consortia, symposia, or editorial roles in biomedical journals could help affirm his leadership in this interdisciplinary field.

🎓 Education:

Rodrigo Navarro Crespo began his academic career with a BSc in Chemistry from the University of Valladolid (Spain) in 2004, earning distinction. He then pursued a PhD in Chemistry at the Complutense University of Madrid, completing it in 2009, also with distinction. His doctoral research focused on developing functional polymers, laying the groundwork for a research career centered on advanced polymer chemistry and materials science. Dr. Navarro has consistently aimed to integrate fundamental chemistry with applied research, which is evident from his later involvement in high-level research projects in Germany and Spain. His educational path reflects a strong commitment to academic excellence and international collaboration. The combination of chemical synthesis, polymer engineering, and sustainable materials has equipped him with a versatile and interdisciplinary academic foundation, ideally suited for innovation in tissue engineering and biomaterials science.

💼 Experience:

Dr. Navarro’s professional journey started as a PhD student at the Instituto de Ciencia y Tecnología de Polímeros (CSIC) from 2004 to 2008. Post-PhD, he worked in Germany at the Institut für Mikrosystemtechnik (IMTEK) (2009–2010), gaining international experience in microsystems and surface modification. Since 2024, he holds a Tenured Scientist position at CSIC, where he leads innovative projects in polymer chemistry. Over his career, he has developed and characterized novel polymeric materials with diverse applications — from biocompatible films and recyclable polymers to smart functional materials. His multidisciplinary experience spans academic research, applied polymer development, and international cooperation. Dr. Navarro’s blend of theoretical knowledge and hands-on research excellence has made him a key figure in advancing sustainable polymer solutions for real-world challenges, aligning well with emerging areas like tissue engineering.

🏅 Awards and Honors:

  • 🎓 Distinction in Chemistry Degree – University of Valladolid, 2002

  • 🎓 Distinction in PhD Chemistry – Complutense University of Madrid, 2009

  • 🏆 Best Paper Award (2020) – European Membrane Society for a publication in Journal of Membrane Science on circular economy and membrane recycling
    Dr. Navarro’s academic distinctions highlight his strong foundational capabilities in chemistry, and his Best Paper Award demonstrates peer-recognized innovation in sustainability-focused research. His scholarly impact is further emphasized by the high citation count of multiple papers, especially in areas like polymer plasticizers and membrane technologies. These recognitions underscore his dedication to impactful, high-quality research — a key qualification for awards in cutting-edge fields such as tissue engineering.

🔬 Research Focus:

Dr. Rodrigo Navarro Crespo’s research centers on advanced polymeric materials with sustainable, functional, and biomedical properties. A core focus has been the modification of PVC and polyurethanes to reduce plasticizer migration — a significant health and environmental issue. He has also developed novel bio-inspired materials, recyclable membranes, and upcycled polyesters, contributing to the circular economy. His work emphasizes green chemistry, high-performance coatings, and functional surfaces, employing photochemical and thermal methods to tailor polymer properties. His recent research aligns with key tissue engineering needs: biocompatibility, controlled degradation, and mechanical robustness. Through collaborative projects, interdisciplinary innovation, and a publication portfolio spanning membrane science, degradation stability, and polymer nanocomposites, Dr. Navarro addresses global challenges like plastic waste and biomedical material safety. His expertise is well-suited to tissue engineering applications where materials science, sustainability, and biofunctionality converge.

📚 Publications Top Notes:

  1. 📄 Phthalate plasticizers covalently bound to PVC: plasticization with suppressed migration – Macromolecules, 2010

  2. 📄 Preparation of surface-attached polymer layers by thermal or photochemical activation of α-diazoester moieties – Langmuir, 2013

  3. 📄 Highly flexible PVC materials without plasticizer migration via trichlorotriazine chemistry – Macromolecules, 2016

  4. 📄 New routes to difunctional macroglycols using ethylene carbonate – Polymer Degradation and Stability, 2017

  5. 📄 Design and synthesis of bio-inspired polyurethane films with high performance – Polymers, 2020

  6. 📄 Coumarins into polyurethanes for smart and functional materials – Polymers, 2020

  7. 🏆 Circular economy in membrane technology: Recycling end-of-life reverse osmosis modules – Journal of Membrane Science, 2020

  8. 📄 Preparation of high molecular weight poly(urethane-urea)s bearing deactivated diamines – Polymers, 2021

  9. 📄 Properties of polyurethanes from poly(diethylene glycol terephthalate) – European Polymer Journal, 2021

  10. 🔄 Chemical upcycling of PET waste: Moving to a circular model – Journal of Polymer Science, 2022

🧾 Conclusion:

Dr. Rodrigo Navarro Crespo is a highly qualified and promising candidate for a Research for Tissue Engineering Award, particularly from the materials development and sustainability angle. His original contributions in polymer chemistry, especially in bio-inspired and functional polymers, offer real value to regenerative medicine through safer, smarter, and more environmentally responsible biomaterials.

Dalia Saleh | Cancer Cell Biology | Innovative Research Award

Published on by Cell Biologist

Prof . Dalia Saleh | Cancer Cell Biology | Innovative Research Award

Prof . Dalia Saleh | National Research Centre | Egypt

Dr. Dalia Osama Abd El Fattah Saleh is a distinguished pharmacologist with over two decades of experience in experimental pharmacology and drug development. She holds a Ph.D. in Pharmacology from Cairo University and currently serves as a Professor at the National Research Centre in Cairo, Egypt. Dr. Saleh has contributed to numerous high-impact scientific journals and has led pioneering work in the areas of metabolic disorders, drug safety, and vascular pharmacology. Her multidisciplinary collaborations and continuous professional development from institutions like King’s College London demonstrate her dedication to excellence in research and education. She is also recognized for her commitment to academic instruction and quality assurance, having served as a Quality Assurance Director. Her work bridges scientific discovery and real-world therapeutic applications, making her a strong candidate for innovation-focused research awards.

publication profile:

scopus

Strengths for the Award:

  1. Robust Academic Background:
    Dr. Saleh holds a Ph.D. in Pharmacology from Cairo University and has a long-standing academic and research career in pharmacology and drug development. Her doctoral and master’s theses reflect a strong foundation in vascular pharmacology, metabolic disorders, and endocrine influence—fields of enduring relevance.

  2. Consistent Research Productivity:
    Her recent publication record (2022–2024) is prolific and impactful, with studies published in high-visibility journals such as Scientific Reports, Biochemistry and Cell Biology, Naunyn-Schmiedeberg’s Archives of Pharmacology, and Environmental Science and Pollution Research. Her work covers cutting-edge pharmacological topics, including:

    • AMPK/mTOR signaling pathways,

    • Neuroprotection and anti-inflammatory mechanisms,

    • Herbal and synthetic compounds in disease modulation,

    • Hepatic encephalopathy, diabetic nephropathy, and cystitis models.

  3. Interdisciplinary and Translational Approach:
    Dr. Saleh bridges basic pharmacological research with clinical relevance. Her investigations into molecular pathways (e.g., NF-κB, PI3K/Akt, SIRT-1) are grounded in disease models, thus demonstrating translational potential. Her inclusion of both natural and synthetic agents further adds diversity and innovation to her research.

  4. Capacity Building and International Exposure:
    She has participated in Continuing Professional Development modules at King’s College London, emphasizing drug safety, statistics, and ethics—key areas in modern drug development. This international engagement underscores her commitment to staying updated and aligned with global standards.

  5. Institutional Contribution and Leadership:
    As a Professor and former Quality Assurance Director at the National Research Centre (NRC), she has contributed to institutional excellence, including achieving ISO 9001/2008 certification. These roles reflect her leadership, organizational, and strategic planning skills.

Areas for Improvement:

  1. Principal Investigator Leadership:
    While her name appears consistently in multi-author studies, further highlighting her role as the principal investigator (PI) or corresponding author could strengthen her case for innovation leadership.

  2. Patents or Product Development:
    There is no mention of patents or direct product development based on her findings. Translating research into tangible therapeutics or clinical trials would significantly elevate her eligibility for innovation-specific awards.

  3. Global Collaborations and Grants:
    Although she has participated in international seminars, active global collaborations or leading major international grants/projects would further establish her as a global innovator.

  4. Public/Industry Impact:
    While the academic impact is strong, showcasing industry partnerships or policy-level influence (e.g., contributions to clinical guidelines or regulatory science) would align more directly with innovation awards that emphasize practical application.

🎓 Education Summary :

Dr. Dalia Saleh completed her higher education at Cairo University’s Faculty of Pharmacy, where she earned her Master of Science in Pharmacology in 2009 and Doctor of Philosophy in Pharmacology in 2012. Her M.Sc. thesis focused on the vascular and biochemical effects of rosiglitazone in diabetic rats, reflecting early interests in metabolic pharmacology. Her Ph.D. expanded on this foundation by exploring estrogen’s potential role in managing vascular changes related to insulin resistance. Both theses demonstrated robust experimental designs and contributed new insights into the interplay between hormonal and metabolic pathways in disease models. Dr. Saleh has since built on this academic background with advanced training in clinical drug development, safety, and biostatistics at King’s College London in 2023, indicating a continued commitment to integrating modern pharmaceutical science and translational research into her academic portfolio. This rich educational foundation underpins her success as a researcher and educator.

🔬 Research Focus :

Dr. Saleh’s research focuses on experimental pharmacology, with a special interest in metabolic diseases, drug-induced toxicities, inflammation, and vascular pharmacology. Her studies frequently involve animal models to investigate the mechanisms of drug action and to evaluate the protective or therapeutic roles of natural products and synthetic compounds. A recurring theme in her work is exploring the modulation of signaling pathways like AMPK, NF-κB, PI3K/mTOR, and Nrf2 in the context of oxidative stress, inflammation, and cellular apoptosis. She has also studied the role of hormonal influences in disease models, such as estrogen’s effect on insulin resistance. Her research employs modern analytical techniques and integrates molecular biology with pharmacodynamics to derive mechanistic insights. This strong focus on mechanistic pharmacology enhances her work’s relevance in drug development, particularly for conditions such as diabetic complications, hepatic encephalopathy, nephropathy, and chemotherapy-induced toxicities.

📚 Publications Top Note:

  1. 🧪 Eugenol alleviates acrylamide-induced testicular toxicity via AMPK/pAKT/mTOR modulation – Scientific Reports, 2024

  2. 🧠 Trimetazidine prevents cisplatin neuropathy through AMPK, Nrf2, and NF-κB pathways – Biochemistry and Cell Biology, 2023

  3. 🔬 Novel chromone-thiazolopyrimidines as TNF-α, IL-6, and PGE2 inhibitors – Polycyclic Aromatic Compounds, 2023

  4. 🚽 Chrysin protects against cyclophosphamide-induced hemorrhagic cystitis via anti-inflammatory signaling – Chemico-Biological Interactions, 2023

  5. 🧃 Linagliptin & L-arginine synergy in gastric hyperacidity via EP4 receptor upregulation – Naunyn-Schmiedeberg’s Archives of Pharmacology, 2023

  6. 🧠 L-arginine reduces thioacetamide-induced hepatic encephalopathy via NF-κB downregulation – Environmental Science and Pollution Research, 2023

  7. 🌿 Calotropis procera seed oil shows anti-inflammatory and antiparasitic activity – Arabian Journal of Chemistry, 2022

  8. 🛡️ Olmesartan mitigates diabetic nephropathy via AGE/PKC and TLR4/SIRT-1 pathways – European Journal of Pharmacology, 2022

  9. 🍃 Plumbago species show anti-fibrotic effects in liver fibrosis rat models – Scientific Reports, 2022

  10. 🫀 Omega-3 combats doxorubicin-induced liver toxicity via Nrf2/PI3K/Akt signaling – Pending Publication

Conclusion:

Dr. Dalia O. Saleh presents a strong candidacy for the Research for Innovative Research Award, particularly due to her sustained publication record, mechanistic depth in pharmacology, and commitment to professional development and institutional excellence. Her work spans innovative mechanistic explorations and novel therapeutic evaluations, showing real promise in addressing current pharmacological challenges.